Data as of Sep 19
| -0.15 / -8.20%|
BioStar Pharmaceuticals, Inc., develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The company's products include AoXing Oleanlic Acid Capsule (treatment for Hepatitis B), Danshen Granule (treatment for coronory heart disease, myocarditis and angina pectoris), GanWang (treatment for colds, runny nose, sore throat, headache and fever), Taohuasan (treatment for bronchial congestion and coughs) and Tianqi Dysmenorrhea Capsule (treatment for dysmenorrhea). BioStar Pharmaceuticals was founded on March 27, 2007 and is headquartered in Xianyang, China.
|Rong Hua Wang||Chairman, President & Chief Executive Officer|
|Zheng Hong Wang||Chief Operating Officer|
|Qing Hua Liu||Chief Financial Officer & Director|
|Gong Shuang||Secretary & Administration Director|
|Xiaohui Zheng||Chief Scientist|